Aripiprazole Lauroxil: Pharmacokinetic Profile of This Long-Acting Injectable Antipsychotic in Persons With Schizophrenia

BACKGROUND: Aripiprazole lauroxil is an extended-release prodrug of aripiprazole for intramuscular injection, approved for schizophrenia treatment. We developed a population pharmacokinetic (PopPK) model to characterize aripiprazole lauroxil PK and evaluate dosing scenarios likely to be encountered...

Descripción completa

Detalles Bibliográficos
Autores principales: Hard, Marjie L., Mills, Richard J., Sadler, Brian M., Turncliff, Ryan Z., Citrome, Leslie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400404/
https://www.ncbi.nlm.nih.gov/pubmed/28350572
http://dx.doi.org/10.1097/JCP.0000000000000691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400404/
https://www.ncbi.nlm.nih.gov/pubmed/28350572
http://dx.doi.org/10.1097/JCP.0000000000000691

Ejemplares similares